Preventing adverse events of chemotherapy for gastrointestinal cancer by educating patients about the nocebo effect: a randomized-controlled trial.

Michnevich, T; Pan, Y; Hendi, A; Oechsle, K; Stein, A; Nestoriuc, Y

Michnevich, T; Pan, Y; Hendi, A; Oechsle, K; Stein, A; Nestoriuc, Y.

Afiliación

Michnevich T; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. twyla.michnevich@charite.de.
Pan Y; Department of Psychiatry and Psychotherapy, Charité - University Medicine Berlin, Berlin, Germany. twyla.michnevich@charite.de.
Hendi A; Present address: Charité - University Medicine Berlin, Berlin, Germany. twyla.michnevich@charite.de.
Oechsle K; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stein A; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nestoriuc Y; Department of Oncology, Asklepios Clinic Barmbek, Hamburg, Germany.

BMC Cancer ; 22(1): 1008, 2022 Sep 23.

Article en En | MEDLINE | ID: mdl-36138381

Asunto(s)

Neoplasias Gastrointestinales; Efecto Nocebo; Femenino; Neoplasias Gastrointestinales/tratamiento farmacológico; Humanos; Masculino; Persona de Mediana Edad

Palabras clave

Adverse events; Chemotherapy; Expectations; Nocebo; Placebo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Efecto Nocebo / Neoplasias Gastrointestinales Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google